BEZ235 twice daily resulted in significant toxicity without objective responses; further development of this compound will not be pursued in this disease.
No takes yet. Share an insight, caveat, or question.
Carlo et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: